Literature DB >> 21737514

Management of patients with membranous nephropathy.

Julia M Hofstra, Jack F M Wetzels.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21737514     DOI： 10.1093/ndt/gfr371

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  23 in total

1.  Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy.

Authors:  Jan A J G van den Brand; Peter R van Dijk; Julia M Hofstra; Jack F M Wetzels
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

2.  Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

3.  Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Xibei Jia; Ruichan Liu
Journal:  Med Princ Pract       Date:  2017-06-19       Impact factor: 1.927

4.  Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.

Authors:  Jan A J G van den Brand; Peter R van Dijk; Julia M Hofstra; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 8.237

Review 5.  Treatment of idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Fernando C Fervenza; Jack F M Wetzels
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

Review 6.  Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.

Authors:  Thilo C von Groote; Gabrielle Williams; Eric H Au; Yizhi Chen; Anna T Mathew; Elisabeth M Hodson; David J Tunnicliffe
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

7.  Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy.

Authors:  Leonella Luzardo; Gabriela Ottati; Jimena Cabrera; Hernando Trujillo; Mariela Garau; Carlota González Bedat; Ruben Coitiño; María H Aunchayna; José Santiago; Graciela Baldovinos; Ricardo Silvariño; Alejandro Ferreiro; Francisco González-Martínez; Liliana Gadola; Oscar Noboa; Hena Caorsi
Journal:  Kidney360       Date:  2020-08-07

Review 8.  Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

Authors:  Yizhi Chen; Arrigo Schieppati; Guangyan Cai; Xiangmei Chen; Javier Zamora; Giovanni A Giuliano; Norbert Braun; Annalisa Perna
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

9.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

Authors:  Anneke P Bech; Julia M Hofstra; Paul E Brenchley; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

10.  Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.

Authors:  Anne-Els van de Logt; Joana Justino; Coralien H Vink; Jan van den Brand; Hanna Debiec; Gérard Lambeau; Jack F Wetzels
Journal:  Kidney Int Rep       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.